Jan 26, 2022 05:47 PM
PODCAST
Caixin China Biz Roundup: Chinese mRNA Jab Activates 80% to 95% Immune Response
Jan.26.2022
Behind the findings of the homegrown shot’s first stage clinical trials; Beijing’s plan to stay smog-free over the Olympics; and China digests a record amount of bad assets
00:00/00:00
Contact senior podcast producer Nandini Venkata （nandinivenkata@caixin.com）
Download our app to receive breaking news alerts and read the news on the go.
Get our weekly free Must-Read newsletter.
Share this article
Open WeChat and scan the QR code
MORE WAYS TO LISTEN
MOST POPULAR
- 1Exclusive: China Widens Tax Net to Offshore Insurance
- 2DeepSeek Releases Official V4-Flash Model as China’s AI Race Intensifies
- 3Beijing Clears Eight New Reactors as China Accelerates Nuclear Buildout
- 4Cover Story: China’s Power Market Enters a More Volatile Era as Prices Go Real Time
- 5China’s Politburo Pledges Incremental Policy Support to Bolster Economy
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas
Sign in with Google
Sign in with Facebook
Sign in with 财新